Startups
Dunad Therapeutics
Develops oral small molecule therapies for neurodegenerative diseases using covalent chemistry to target disease-driving proteins. Its programs include ALS therapies aimed at reducing toxic TDP-43 buildup and treatments for Parkinson’s disease.
Team
Elizabeth RoperBoard Member |
 Lucy Edwardes JonesBoard Member |
Oskar SlotboomBoard Member |
Pearl HuangPresident and CEO |
Rebecca BownChief Financial Officer |
Stephen HuhnChief Medical Officer |
Varun GuptaBoard Member |